Stocks

MicroStrategy (NASDAQ:MSTR) Shares Gap Up - Is It Time to Buy?

Published November 27, 2024

MicroStrategy Incorporated (NASDAQ:MSTR) saw its share price jump significantly before trading commenced on Wednesday. The stock, which had closed the previous day at $353.69, opened at $384.29. It was last traded at $385.50, with a notable trading volume of 6,126,708 shares.

Wall Street Analysts Forecast Growth

Recent assessments from various research firms indicate an optimistic outlook for MicroStrategy. Barclays raised their price target for the company from $275.00 to $515.00 and has assigned it an "overweight" rating in their latest research note. Meanwhile, Cantor Fitzgerald began coverage of MicroStrategy on August 21st with a price target of $194.00 and also issued an "overweight" rating. In a recent report, Benchmark raised their price objective from $450.00 to $650.00, giving MicroStrategy a "buy" rating. Furthermore, Canaccord Genuity increased their target from $300.00 to $510.00, while TD Cowen upped their price target from $392.00 to $525.00. Out of the analysts, one rated the stock as a sell, while eight others rated it as a buy. Currently, the consensus rating for MSTR stands at "Moderate Buy" with an average price target of $479.25.

MicroStrategy Trading Performance

MicroStrategy shares have shown notable trading performance, jumping 6.8% recently. Despite the volatility, there is potential for further gains—some analysts suggest that the stock could see a rise of 50%. However, investors should be prepared for fluctuations in price.

Company Financials

The company's financial health appears mixed. As of the most recent analysis, MicroStrategy has a debt-to-equity ratio of 1.12, and both the current and quick ratios stand at 0.65. The stock's moving averages indicate strong price momentum, with a 50-day moving average of $243.51 and a 200-day moving average of $180.24. MicroStrategy’s market capitalization sits at $76.54 billion, but it has a negative P/E ratio of -181.77 and a high beta of 3.05, suggesting more volatility compared to the broader market.

Recent Earnings Results

On October 30th, MicroStrategy announced its latest earnings, reporting a loss of ($1.56) per share, which was significantly below the consensus estimate of ($0.12). The company also posted a negative return on equity of 17.31% and a net margin of -87.05%. Revenue for the quarter reached $116.07 million, though this was lower than the expected $121.45 million, marking a 10.3% decline year-over-year from the previous year when they reported revenues of $129.17 million.

Insider Selling Activities

In insider activity, Director Stephen X. Graham sold 20,000 shares at an average price of $451.36, generating $9,027,200. Following the transaction, he owns just 6,970 shares, representing a 74.16% decrease in his overall holding. CFO Andrew Kang also sold 5,700 shares at an average price of $257.15. Insiders collectively sold 102,000 shares worth $32,259,177 in the past three months, which could indicate a lack of confidence in the stock’s short-term prospects.

Institutional Investor Activity

Many hedge funds have recently adjusted their holdings in MicroStrategy, with some increasing their stakes. For instance, Canada Life Assurance Co enhanced its ownership by 19.6%, while other institutional investors like Public Employees Retirement Association of Colorado and California State Teachers Retirement System also boosted their investments significantly, driving institutional ownership to about 72.03% of the stock.

Conclusion

MicroStrategy provides enterprise analytics software and services, leveraging artificial intelligence. As the technology sector evolves, investor sentiment around this stock remains mixed. With its latest price surge, potential investors are left wondering if now is the right time to buy MSTR or if they should look for alternative options. The consensus among analysts sways toward a favorable outlook, but past performance and the latest earnings do raise some cautionary flags for potential buyers.

MicroStrategy, NASDAQ, stocks